Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Micafungin sodium | C56H72N9NaO23S | 208538-73-2 | Details |
| Canagliflozin | C24H25FO5S | 842133-18-0 | Details |
| DOTA-NHS-ester | C20H31N5O10 | 170908-81-3 | Details |
| DSPE-PEG5-propargyl | C55H104NO14P | 2112737-93-4 | Details |
| Thalidomide-O-amido-PEG2-C2-NH2 TFA | C23H27F3N4O10 | 1957235-75-4 | Details |
| E3 ligase Ligand 9 | C21H32N2O6 | 87304-15-2 | Details |
| VH032-cyclopropane-F | C26H33FN4O5S | 2306193-99-5 | Details |
| (S,R,S)-AHPC-C10-NH2；VH032-C10-NH2 | C33H51N5O4S | 2341796-74-3 | Details |
| DBCO-PEG9-DBCO | C58H70N4O13 | 2353409-50-2 | Details |
| cIAP1 Ligand-Linker Conjugates 12；E3 ligase Ligand-Linker Conjugates 38 | C46H64N4O12S2 | 2095244-52-1 | Details |
| EC1167 | C33H45N7O17S | 1610414-00-0 | Details |
| Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
| DSPE-PEG4-DBCO | C71H116N3O15P | 2112738-14-2 | Details |
| Thalidomide-O-amido-C8-NH2；E3 Ligase Ligand-Linker Conjugates 20;Cereblon Ligand-Linker Conjugates 2 | C23H30N4O6 | 1950635-15-0 | Details |
| (S,R,S)-AHPC-C6-PEG3-C4-Cl | C38H59ClN4O7S | 1835705-55-9 | Details |
| (S,R,S)-AHPC-PEG3-NH2；E3 ligase Ligand-Linker Conjugates 5 Free Base;VH032-PEG3-NH2;VHL Ligand-Linker Conjugates 1 | C30H45N5O7S | 2010159-56-3 | Details |
| endo-BCN-PEG3-NHS ester | C24H34N2O9 | 2101206-94-2 | Details |
| E3 ligase Ligand 8 | C31H34N2O6 | 1225383-33-4 | Details |
| DM4-SMCC | C54H72ClN5O16S | 1228105-52-9 | Details |
| DBCO-PEG6-amine | C33H45N3O8 | 2353409-98-8 | Details |
| Nutlin carboxylic acid；MDM2 ligand 1;E3 ligase Ligand 16 | C32H32Cl2N4O6 | 2249750-27-2 | Details |
| FAK ligand-Linker Conjugate 1 | C25H28F3N5O6S | 2307461-45-4 | Details |
| Estrone-N-O-C1-amido；ERα ligand 1 | C20H26N2O3 | 138219-84-8 | Details |
| E3 ligase Ligand 14 | C38H52N4O7 | 2241489-43-8 | Details |
| cIAP1 Ligand-Linker Conjugates 15；E3 ligase Ligand-Linker Conjugates 34 | C37H47N3O8 | 1225433-96-4 | Details |
| Otenabant hydrochloride | C25H26Cl3N7O | 686347-12-6 | Details |
| LXR-623 | C21H12ClF5N2 | 875787-07-8 | Details |
| (S,R,S)-AHPC-PEG1-N3 | C26H35N7O5S | 2101200-09-1 | Details |
| Diethylene glycol bis(p-toluenesulfonate) | C18H22O7S2 | 7460-82-4 | Details |
| Lenalidomide-C5-NH2；E3 ligase Ligand-Linker Conjugates 31;Cereblon Ligand-Linker Conjugates 19 | C18H23N3O3 | 2093388-45-3 | Details |
| (S,R,S)-AHPC-PEG3-N3 | C30H43N7O7S | 1797406-80-4 | Details |
| E3 ligase Ligand 10 | C47H52N4O7 | 1073560-68-5 | Details |
| VHL Ligand-Linker Conjugates 15；E3 Ligase Ligand-Linker Conjugates 56 | C37H45FN4O8S | 2375564-62-6 | Details |
| Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
| Di(N-succinimidyl)adipate | C14H16N2O8 | 59156-70-6 | Details |
| Daclatasvir dihydrochloride | C40H51ClN8O6 | 1009119-65-6 | Details |
| DSPE-PEG8-Mal | C64H119N2O19P | 2112737-94-5 | Details |
| (S,R,S)-AHPC-PEG2-C4-Cl；VH032-PEG2-C4-Cl;VHL Ligand-Linker Conjugates 7;E3 ligase Ligand-Linker Conjugates 10 | C32H47ClN4O6S | 1835705-57-1 | Details |
| DM4-SPDP | C45H61ClN4O14S2 | 2245698-48-8 | Details |
| DNP-PEG4-DBCO | C35H39N5O10 | 2149585-17-9 | Details |
| DMAC-SPP | C17H21N3O5S2 | 663599-10-8 | Details |
| Fmoc-Gly-Gly-Phe-OtBu | C32H35N3O6 | 236426-37-2 | Details |
| Dde Biotin-PEG4-TAMRA-PEG4 Alkyne | C72H100N9O18S+ | 2353409-55-7 | Details |
| cIAP1 Ligand-Linker Conjugates 5；E3 ligase Ligand-Linker Conjugates 39 | C37H55N5O8S | 2113688-20-1 | Details |
| Fmoc-Ala-Ala-Asn(Trt)-OH | C44H42N4O7 | 1951424-92-2 | Details |
| Fmoc-N-PEG20-acid | C58H97NO24 | 1952360-93-8 | Details |
| (S,R,S)-AHPC-PEG6-C4-Cl；VHL Ligand-Linker Conjugates 10;VH032-PEG6-C4-Cl;E3 ligase Ligand-Linker Conjugates 9 | C40H63ClN4O10S | 1835705-59-3 | Details |
| (S,R,S)-AHPC-PEG2-NH2；VH032-PEG2-NH2;VHL Ligand-Linker Conjugates 3;E3 ligase Ligand-Linker Conjugates 6 Free Base | C28H41N5O6S | 2010159-60-9 | Details |
| Fmoc-Ala-Ala-Asn-PABC-PNP | C39H38N6O11 | 1834516-06-1 | Details |
| E3 ligase Ligand 18 | C17H17ClN6O4S | 2241669-88-3 | Details |
| cIAP1 Ligand-Linker Conjugates 14；E3 ligase Ligand-Linker Conjugates 36 | C39H49N3O10 | 1351169-40-8 | Details |
| Levobupivacaine | C18H28N2O | 27262-47-1 | Details |
| Fmoc-NH-PEG12-CH2CH2COOH | C42H65NO16 | 1952360-91-6 | Details |
| Thalidomide-O-amido-C3-COOH；E3 ligase Ligand-Linker Conjugates 15;Cereblon Ligand-Linker Conjugates 7 | C19H19N3O8 | 2308035-51-8 | Details |
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride | C30H46ClN5O7S | 2097971-11-2 | Details |
| exo BCN-O-PNB | C17H17NO5 | 1380006-72-3 | Details |
| Pomalidomide-C2-NH2；Cereblon Ligand-Linker Conjugates 15;4-[(2-Aminoethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C15H16N4O4 | 1957235-66-3 | Details |
| Pomalidomide-PEG3-C2-NH2；E3 ligase Ligand-Linker Conjugates 30;Cereblon Ligand-Linker Conjugates 5 | C21H28N4O7 | 2093416-31-8 | Details |
| DMAC-PDB | C12H16N2O3S2 | 663599-04-0 | Details |
| cIAP1 ligand 2；E3 ligase Ligand 11 | C34H40N4O6S | 2357114-70-4 | Details |
| cIAP1 Ligand-Linker Conjugates 11；E3 ligase Ligand-Linker Conjugates 33 | C35H43N3O7 | 1239943-19-1 | Details |
| Fosaprepitant dimeglumine | C30H39F7N5O11P | 265121-04-8 | Details |
| DBCO-PEG5-DBCO | C50H54N4O9 | 2363130-04-3 | Details |
| (S,R,S)-AHPC-(C3-?PEG)?2-?C6-?Cl；VHL Ligand-Linker Conjugates 11;E3 ligase Ligand-Linker Conjugates 11 | C39H61ClN4O6S | 1835705-61-7 | Details |
| Fmoc-Asp-NH2 | C19H18N2O5 | 200335-40-6 | Details |
| EC089 | C36H46N14O14S | 625827-91-0 | Details |
| Diketone-PEG4-Biotin | C33H50N4O9S | 2353409-85-3 | Details |
| cIAP1 Ligand-Linker Conjugates 1；E3 ligase Ligand-Linker Conjugates 41 | C42H57N5O9S | 2357114-75-9 | Details |
| GW9508 | C22H21NO3 | 885101-89-3 | Details |
| MBX-2982 | C22H24N8OS | 1037792-44-1 | Details |
| Ceritinib dihydrochloride | C28H37Cl2N5O3S | 1380575-43-8 | Details |
| DSPE-PEG5-azide | C54H105N4O14P | 2112737-73-0 | Details |
| Pomalidomide-PEG4-C2-NH2 | C23H32N4O8 | 2225940-52-1 | Details |
| endo-BCN-PEG3-NH2 | C19H32N2O5 | 1883512-27-3 | Details |
| DBCO-PEG9-amine | C39H57N3O11 | 2353409-99-9 | Details |
| Fluorescein-PEG5-NHS ester | C38H41N3O14S | 2353409-62-6 | Details |
| cIAP1 Ligand-Linker Conjugates 11 Hydrochloride；E3 ligase Ligand-Linker Conjugates 33 Hydrochloride | C35H44ClN3O7 | 1239866-59-1 | Details |
| cIAP1 Ligand-Linker Conjugates 2；E3 ligase Ligand-Linker Conjugates 37 | C37H48N4O7 | 1312302-14-9 | Details |
| Fmoc-Gly-Gly-OH | C19H18N2O5 | 35665-38-4 | Details |
| Ceritinib | C28H36ClN5O3S | 1032900-25-6 | Details |
| Tazemetostat | C34H44N4O4 | 1403254-99-8 | Details |
| DSPE-PEG4-acid | C52H100NO15P | 2112738-58-4 | Details |
| Thalidomide-O-amido-C4-NH2；Cereblon Ligand-Linker Conjugates 6;E3 Ligase Ligand-Linker Conjugates 19 | C19H22N4O6 | 1799711-24-2 | Details |
| (S,R,S)-AHPC-PEG2-NH2 hydrochloride | C28H42ClN5O6S | 2097973-72-1 | Details |
| (S,R,S)-AHPC-PEG4-N3 | C32H47N7O8S | 1797406-81-5 | Details |
| (S,R,S)-AHPC TFA | C24H31F3N4O5S | 1631137-51-3 | Details |
| Thalidomide-O-amido-C6-NH2 TFA | C23H27F3N4O8 | 1950635-14-9 | Details |
| endo-BCN-PEG3-mal | C26H37N3O8 | 2141976-33-0 | Details |
| endo-BCN-PEG2-C2-NHS ester | C22H30N2O8 | 2243565-12-8 | Details |
| cIAP1 Ligand-Linker Conjugates 3；E3 ligase Ligand-Linker Conjugates 40 | C39 H56 N4 O11 S | 2222354-20-1 | Details |
| cIAP1 ligand 1；E3 ligase Ligand 12 | C31H42N4O6S | 2095244-42-9 | Details |
| cIAP1 Ligand-Linker Conjugates 15 hydrochloride；E3 ligase Ligand-Linker Conjugates 34 hydrochloride | C37H48ClN3O8 | 1225383-36-7 | Details |
| Obeticholic Acid | C26H44O4 | 459789-99-2 | Details |
| (S,R,S)-AHPC-PEG2-N3 | C28H39N7O6S | 2010159-45-0 | Details |
| Thalidomide-O-amido-PEG3-C2-NH2；E3 Ligase Ligand-Linker Conjugates 14;Cereblon Ligand-Linker Conjugates 3 | C23H30N4O9 | 1957236-20-2 | Details |
| Everolimus | C53H83NO14 | 159351-69-6 | Details |
| (4R,5S)-nutlin carboxylic acid；MDM2 ligand 2;E3 ligase Ligand 15 | C32 H32 Cl2 N4 O6 | 2306390-08-7 | Details |
| Pomalidomide-PEG1-C2-N3；Cereblon Ligand-Linker Conjugates 13;E3 ligase Ligand-Linker Conjugates 50 | C17H18N6O5 | 2271036-44-1 | Details |
| Diketone-PEG4-PFP ester | C30H34F5NO9 | 2353409-84-2 | Details |
| Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH；E3 ligase Ligand-Linker Conjugates 49;Cereblon Ligand-Linker Conjugates 14 | C31H44N4O11 | 2351103-63-2 | Details |
| Product Total： Product Page： | ||||
| 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 | ||||